Carbonylamino pyrrolopyrazoles, potent kinase inhibitors

Details for Australian Patent Application No. 2006327866 (hide)

Owner Pfizer Products Inc.

Inventors Guo, Changxing; Johnson, Mary Catherine; Tikhe, Jayashree Girish; Kephart, Susan Elizabeth; Mcalpine, Indrawn James; Li, Haitao; Hong, Yufeng; Dong, Liming; Yang, Anle; Zhang, Junhu

Agent Shelston IP

Pub. Number AU-B-2006327866

PCT Pub. Number WO2007/072153

Priority 60/753,349 21.12.05 US; 60/864,932 08.11.06 US

Filing date 12 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 14 June 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/072153 Priority application(s): WO2007/072153

14 June 2012 Application Accepted

  Published as AU-B-2006327866

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006327871-Pyrimidine derivatives for the treatment of abnormal cell growth

2006327865-Clear and thickening aqueous compositions, the use thereof in acidic aqueous formulations, and the resulting formulations